Principles of Antimicrobial Therapy & Pharmacotherapy for Respiratory Disorders, Anita Douglas Shadow Health Assessment

Principles of Antimicrobial Therapy & Pharmacotherapy for Respiratory Disorders The ShadowHealth© virtual assignment on Focused Exam: Community-Acquired Pneumonia (CAP) involving Anita Douglas provided a comprehensive and immersive experience in clinical decision-making and patient management. This introspective journey encompasses not just the diagnostic procedures and symptom checklist but also the feelings, moral decisions, and critical thinking that the holistic approach to patient treatment requires. Follow me as I navigate the virtual hospital hallways, diagnosing and treating community-acquired pneumonia with the knowledge I have gathered from the complex dance between theory and practice, technology and empathy, and, eventually, technology and art. The virtual environment of ShadowHealth© led me through several diagnostic tasks and made me consider the relationship between academic knowledge and its practical implementation. My classroom learning transformed into an actual comprehension of the difficulties involved in community-acquired illnesses because of Anita Douglas, a virtual representation of a patient suffering from pneumonia. Medication Prescribing Considerations Initial treatment strategies should be based on the organism most likely to have caused the pneumonia and the patient's comorbidities, according to Virginia Poole Arcangelo et al. (2021). Comorbidities include renal, chronic heart, liver, lung disease, malignancy, diabetes mellitus, alcoholism, and asplenia. Community-Acquired Pneumonia (CAP) can be brought on by bacterial or viral infections, either by themselves or in combination. Antimicrobial therapy should be customized for a specific bacterium if cultures are collected and an organism is identified. Empirical antibiotics should be started to address most species that are most likely to 3 cause community-acquired pneumonia (CAP), including S. pneumoniae, H. influenza, and atypical organisms, as most patients do not have culture data available at the time of diagnosis. In evaluating Anita Douglas's condition and symptoms indicative of CommunityAcquired Pneumonia (CAP), the decision to prescribe medications hinges on a careful consideration of her clinical presentation and underlying health status. According to the Infectious Diseases Society of America (IDSA) guidelines (Metlay et al., 2019), the recommended first-line therapy for non-severe Community-Acquired Pneumonia (CAP) in adults without comorbidities includes antibiotics such as macrolides (azithromycin, clarithromycin) or doxycycline. Given Anita's medical history of hypertension and chronic kidney disease stage II, we are unable to prescribe the first line of antibiotics commonly given for Community-Acquired Pneumonia (CAP). Amoxicillin/clavulanate (Augmentin) is a combination antibiotic that includes amoxicillin and clavulanate potassium (Lee et al., 2018). It is often prescribed for Community-Acquired Pneumonia (CAP) when patients have comorbidities due to its broader spectrum of activity and ability to address potentially resistant bacterial strains.